Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma. [electronic resource]
Producer: 20160706Description: 184-93 p. digitalISSN:- 1476-5829
- Animals
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Brazil
- Carmustine -- administration & dosage
- Disease-Free Survival
- Dog Diseases -- diagnosis
- Dogs
- Fat Emulsions, Intravenous -- administration & dosage
- Female
- Kaplan-Meier Estimate
- Lymphoma, B-Cell -- diagnosis
- Lymphoma, T-Cell -- diagnosis
- Male
- Pilot Projects
- Prednisone -- administration & dosage
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.